欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/V/0029/001
药品名称Xylamidor 20 mg/ml solution for injection
活性成分
    • xylazine hydrochloride 23.32 mg
剂型Solution for injection
上市许可持有人VetViva Richter GmbH Feldgasse 19 4600 Wels Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Germany (DE)
    • Latvia (LV)
    • Denmark (DK)
    • Bulgaria (BG)
    • Belgium (BE)
      Xylamidor 20 mg/ml
    • Cyprus (CY)
    • Netherlands (NL)
    • Romania (RO)
    • Ireland (IE)
    • Slovakia (SK)
    • France (FR)
      XYLADOR 20 MG/ML SOLUTION INJECTABLE
    • Slovenia (SI)
    • Spain (ES)
许可日期2023/05/03
最近更新日期2023/07/14
药物ATC编码
    • QN05CM92 xylazine
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase